C000230211 Fees and Costs — Allspring Dynamic Target 2035 Fund, Administrator Class

Data updated: 2024-01-26

The net expense ratio is 0.49% (0.84% before fee waivers). There are no sales loads or redemption fees. In fiscal 2023 the fund paid $15K in broker commissions, 0.0231% of average net assets, and portfolio turnover was 75%.

C000230211 Fees and Expenses

Annual operating expenses and sales charges of C000230211. Prospectus, as of June 30, 2023.

Annual operating expenses
Management fee0.10%
12b-1 fee0.00%
Other expenses0.62%
Gross expense ratio0.84%
Fee waiver−0.35%
Net expense ratio0.49%
Sales charges
Max front load0.00%
Max deferred load0.00%
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentNo

C000230211 Costs Over Time

On $10,000 invested in C000230211, assuming 5% a year before costs, total costs come to $324 over 5 years, cutting the return by 0.54% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.49%)$51$161$281
Trading costs (broker commissions)$2$8$13
Lost growth on money paid in costs$0$8$30
Total costs$54$177$324
Value after costs$10,446$11,399$12,439
Impact on return, per year0.54%0.54%0.54%

C000230211 Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending February 28, 2023.

  • Explicit cost rate (commissions ÷ average net assets): 0.0231%
  • Total broker commissions: $15K
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 75%
  • Securities lending: none during the year

C000230211 Agency Brokers

Commissions paid.

BrokerAmountShare
Goldman Sachs & Co. LLC$15K100.00%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.